<DOC>
	<DOCNO>NCT00175916</DOCNO>
	<brief_summary>This trial , evaluate long-term safety tolerability brivaracetam , give subject suffer epilepsy , may benefit brivaracetam , opportunity continue treatment . The study also evaluate maintenance efficacy time brivaracetam subject partial onset seizure ( POS ) /primary generalize seizure ( PGS ) .</brief_summary>
	<brief_title>Follow-up Trial Evaluate Long-term Safety Efficacy Brivaracetam Subjects Suffering From Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Male/female subject 16 year ( legally permit ethically accept ) 18 year onwards suffer epilepsy complete previous study brivaracetam adjunctive treatment , allow access study Subjects POS/PGS : inpatient outpatient epilepsy participate previous brivaracetam study / program allow access present study Subjects ULD : inpatient outpatient epilepsy treat brivaracetam previous study / program allow access present study Subjects Investigator believe reasonable benefit longterm administration brivaracetam may expect Severe medical , neurological psychiatric disorder , laboratory value may impact safety subject Poor compliance visit schedule medication intake previous brivaracetam study Participation clinical study another investigational drug device study Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Brivaracetam</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>long term</keyword>
</DOC>